摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4,5-dihydro-3-<2-(3-methoxyphenyl)-2-oxoethyl>-1-methyl-1H-imidazolium bromide | 121704-53-8

中文名称
——
中文别名
——
英文名称
4,5-dihydro-3-<2-(3-methoxyphenyl)-2-oxoethyl>-1-methyl-1H-imidazolium bromide
英文别名
1-(3-Methoxyphenyl)-2-(3-methyl-4,5-dihydroimidazol-3-ium-1-yl)ethanone;bromide
4,5-dihydro-3-<2-(3-methoxyphenyl)-2-oxoethyl>-1-methyl-1H-imidazolium bromide化学式
CAS
121704-53-8
化学式
Br*C13H17N2O2
mdl
——
分子量
313.194
InChiKey
MGFDRPXDBRMOFG-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.13
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    32.6
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    1-甲基-4,5-二氢咪唑2-溴-3‘-甲氧基苯乙酮乙腈 为溶剂, 反应 24.0h, 以66%的产率得到4,5-dihydro-3-<2-(3-methoxyphenyl)-2-oxoethyl>-1-methyl-1H-imidazolium bromide
    参考文献:
    名称:
    Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides
    摘要:
    Blood glucose levels in viable, yellow, obese, diabetic mice are reduced following oral administration of phenacylimidazolium halides. Compounds 2 and 3 produced reductions of ca. 40% 2 h after doses of 100 mg/kg po. Since these mice do not respond to sulfonylureas, the glucose-lowering activity of phenacylimidazolium salts in this model suggests a mechanism other than that of stimulating insulin secretion. Only phenacylimidazolium halides with electron-donating groups were active; other azolium salts or variations in the phenacyl portion (alterations in the keto function; chain lengthening or extensive branching) produced inactive compounds.
    DOI:
    10.1021/jm00130a013
点击查看最新优质反应信息

文献信息

  • Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides
    作者:Samuel J. Dominianni、Terence T. Yen
    DOI:10.1021/jm00130a013
    日期:1989.10
    Blood glucose levels in viable, yellow, obese, diabetic mice are reduced following oral administration of phenacylimidazolium halides. Compounds 2 and 3 produced reductions of ca. 40% 2 h after doses of 100 mg/kg po. Since these mice do not respond to sulfonylureas, the glucose-lowering activity of phenacylimidazolium salts in this model suggests a mechanism other than that of stimulating insulin secretion. Only phenacylimidazolium halides with electron-donating groups were active; other azolium salts or variations in the phenacyl portion (alterations in the keto function; chain lengthening or extensive branching) produced inactive compounds.
查看更多